Neutropenic Patient, a Full Unit, and Construction Dust

Ranking, by time-to-harm:

1. The fever. ANC 280 with a temperature of 38.4 °C is febrile neutropenia - a medical emergency with a mortality that climbs with every hour antibiotics are delayed. This outranks every exposure risk because the threat is already inside her.
2. Construction dust. Ceiling work aerosolizes Aspergillus spores, and an open door defeats the protective environment. Invasive mold infection in a transplant recipient is often fatal and hard to treat.
3. Influenza boarder. Influenza is spread by droplet and would be catastrophic in a patient who cannot mount a response; a shared room with a coughing, unmasked patient is not negotiable.
4. Symptomatic visitor and child. Lower immediate risk than the above, but the child is also a fomite factory and is typically excluded from protected rooms by policy.

First three actions:

• Assess her (full vital signs, oxygen saturation, and a deliberate hunt for the source: oral mucosa, line exit site and each lumen, lungs, skin folds, perianal area) and obtain blood cultures - one set per lumen plus a peripheral set if accessible - then give the ceftazidime. Do not delay antibiotics waiting for cultures beyond the collection itself; the target is under 60 minutes.
• Refuse the boarder, state the reason to the charge nurse and document the refusal, and suggest a cohort or transfer option rather than a neutral 'okay.'
• Close her door, stop the cart from propping it, and ask facilities for containment (sealing barriers, HEPA filtration, wet mopping) before work continues.

Notify the provider and expect admission orders with broad-spectrum coverage plus a lactic acid level and fluid resuscitation.

Brother and child: Use a firm, non-punitive script. 'I'm glad you came - she needs family. Your cold could put her in the ICU, so I need you to visit another day, and children under 12 aren't allowed in this room because of the infection risk.' Reasoning: he is not a rule-breaker, he is a source of droplet and contact pathogens in a patient with essentially no neutrophils, and the child is both symptom-prone and a carrier of respiratory viruses. Offer the workaround that preserves support: a video call now, a masked, symptom-free visit later, hand hygiene at the door, and a screen at the doorway if she is isolated.

Thermometer: Decline, and explain why it matters rather than just citing policy. Shared electronic thermometers and reusable cuffs are documented vehicles for organisms moving between rooms - exactly the transfer route that turns one colonized patient into a unit-wide problem. Retrieve a functioning thermometer for the boarder, or have the other nurse use a disposable or dedicated unit. For your patient, keep single-patient equipment at the bedside, clean and disinfect between uses with a facility-approved product, and perform hand hygiene before and after every contact.

Also correct: the boarder's nurse should not be entering a protective-environment room at all unless needed; if entry is required, follow the room's signage for gown, gloves, and mask.

Give the antibiotic now, after cultures are drawn - do not wait for results.

• In febrile neutropenia, mortality rises with each hour of delay to empiric coverage. Culture results take 24 to 72 hours; the patient cannot wait that long, and the standard of care is cultures first (a few minutes that do not delay treatment meaningfully), then immediate broad-spectrum therapy.
• The choice of agent is empiric precisely because the organism is unknown; ceftazidime or an equivalent antipseudomonal beta-lactam is chosen to cover the most likely and most lethal pathogens, including Pseudomonas.
• Waiting would also mean the order sits unadministered, which you would have to document as a delay - a defensible one only if the patient refused or access was lost, not because someone wanted to wait for a lab.

What to say: 'Cultures are drawn and on the way. I'm giving the dose now per the standing febrile neutropenia protocol; please call me with sensitivities when they return so we can narrow coverage.'

What to monitor after the dose: vital signs and mental status, urine output, repeat cultures if the fever persists past 48 to 72 hours, and signs of sepsis or anaphylaxis. Also reassess the source - mucositis may need topical analgesia and oral care, and the line site deserves a close look. Document the draw time, the administration time, and the pharmacist conversation. If the fever does not respond, expect imaging and possible antifungal coverage.